Clinical Trials Directory

Trials / Completed

CompletedNCT02861196

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This research aims to explore the therapeutic effect of neoadjuvant chemotherapy in muscular invasive bladder cancer of T2-4aN0M0, and the survival effect of combined-modality treatment model,then to clarify the probability of bladder preservation, corresponding cancer specific survival, and the quality of life.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntensity modulated radiation therapy, Radical cystectomyPostoperative Intensity modulated radiation therapy(IMRT) will be applied to effective team.Radical cystectomy will be applied to ineffective team.

Timeline

Start date
2015-09-01
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2016-08-10
Last updated
2020-12-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02861196. Inclusion in this directory is not an endorsement.